Improving the physiological realism of experimental models

Interface Focus

Volumn 6, Issue 2, 2016, Pages

  Vinnakota, Kalyan C ^a   Cha, Chae Y ^b   Rorsman, Patrik ^b   Balaban, Robert S ^c   Gerche, Andre La ^d   Wade Martins, Richard ^b   Beard, Daniel A ^a   Jeneson, Jeroen A L ^e,f  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Experimental models; Human; Physiology

Indexed keywords

EID: 84958825084     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2015.0076     Document Type: Review

References (112)

1. Beard DA, Bassingthwaighte JB, Greene AS. 2005 Computational modeling of physiological systems. Physiol. Genomics 23, 1–3. (doi:10.1152/physiolgenomics.00117.2005)
2. Beard DA, Kushmerick MJ. 2009 Strong inference for systems biology. PLoS Comput. Biol. 5, e1000459. (doi:10.1371/journal.pcbi.1000459)
3. Chance B, Garfinkel D, Higgins J, Hess B. 1960 Metabolic control mechanisms. 5. A solution for the equations representing interaction between glycolysis and respiration in ascites tumor cells. J. Biol. Chem. 235, 2426–2439.
4. Tomita M. 2001 Whole-cell simulation: a grand challenge of the 21st century. Trends Biotechnol. 19, 205–210.(doi:10.1016/S0167-7799(01)01636-5)
5. Viceconti M, Clapworthy G, Van Sint Jan S. 2008 The virtual physiological human—a European initiative for in silico human modelling. J. Physiol. Sci. 58, 441–446. (doi:10.2170/physiolsci.RP009908)
6. Hunter P et al. 2010 A vision and strategy for the virtual physiological human in 2010 and beyond. Phil. Trans. R. Soc. A 368, 2595–2614. (doi:10.1098/rsta.2010.0048)
7. de Bono B, Hunter P. 2012 Integrating knowledge representation and quantitative modelling in physiology. Biotechnol. J. 7, 958–972. (doi:10.1002/biot.201100304)
8. Schmitz JP, Vanlier J, van Riel NA, Jeneson JA. 2011 Computational modeling of mitochondrial energy transduction. Crit. Rev. Biomed. Eng. 39, 363–377. (doi:10.1615/CritRevBiomedEng.v39.i5.20)
9. Nicholls DG, Ferguson SJ. 2013 Bioenergetics, 4th edn, pxiv, 419 p. Amsterdam, The Netherlands: Academic Press.
10. Hogeboom GH, Schneider WC, Pallade GE. 1948 Cytochemical studies of mammalian tissues; isolation of intact mitochondria from rat liver; some biochemical properties of mitochondria and submicroscopic particulate material. J. Biol. Chem. 172, 619–635.
11. Claude A. 1946 Fractionation of mammalian liver cells by differential centrifugation: II. Experimental procedures and results. J. Exp. Med. 84, 61–89. (doi:10.1084/jem.84.1.61)
12. Chance B, Williams GR. 1955 Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J. Biol. Chem. 217, 383–393.
13. Chance B, Hagihara B (eds). 1963 Direct spectroscopic measurements of interaction of components of the respiratory chain with ATP, ADP, phosphate and uncoupling agents. In Proc. of the Fifth Int. Congress of Biochemistry, Moscow, Russia, 10–16 August 1961. Oxford, UK: Pergamon Press.
14. de Duve C. 1967 Criteria of homogeneity and purity of mitochondria. In Methods in enzymology, vol. 10 (eds RW Estabrook, ME Pullman), pp. 7–18. New York, NY: Academic Press.
15. LaNoue KF, Bryla J, Williamson JR. 1972 Feedback interactions in the control of citric acid cycle activity in rat heart mitochondria. J. Biol. Chem. 247, 667–679.
16. Bishop PD. 1979 Factors affecting the regulation of mitochondrial respiration. Los Angeles, CA: The University of California.
17. Bishop PD, Atkinson DE. 1984 Adenine nucleotide control of the rate of oxygen uptake by rat heart mitochondria over a 15-to 20-fold range. Arch. Biochem. Biophys. 230, 335–344. (doi:10.1016/0003-9861(84)90116-4)
18. Jeneson JA, Wiseman RW, Westerhoff HV, Kushmerick MJ. 1996 The signal transduction function for oxidative phosphorylation is at least second order in ADP. J. Biol. Chem. 271, 27995–27998. (doi:10.1074/jbc.271.45.27995)
19. Denton RM, McCormack JG, Edgell NJ. 1980 Role of calcium ions in the regulation of intramitochondrial metabolism. Effects of Naþ, Mg2þ and ruthenium red on the Ca2þ-stimulated oxidation of oxoglutarate and on pyruvate dehydrogenase activity in intact rat heart mitochondria. Biochem. J. 190, 107–117. (doi:10.1042/bj1900107)
20. McCormack JG, Denton RM. 1989 The role of Ca2þ ions in the regulation of intramitochondrial metabolism and energy production in rat heart. Mol. Cell Biochem. 89, 121–125. (doi:10.1007/BF00220763)
21. Territo PR, French SA, Dunleavy MC, Evans FJ, Balaban RS. 2001 Calcium activation of heart mitochondrial oxidative phosphorylation—Rapid kinetics of m(V) over dot (O2), NADH, and light scattering. J. Biol. Chem. 276, 2586–2599. (doi:10.1074/jbc.M002923200)
22. Territo PR, French SA, Balaban RS. 2001 Simulation of cardiac work transitions, in vitro: effects of simultaneous Ca2þ and ATPase additions on isolated porcine heart mitochondria. Cell Calcium 30, 19–27. (doi:10.1054/ceca.2001.0211)
23. Bose S, French S, Evans FJ, Joubert F, Balaban RS. 2003 Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J. Biol. Chem. 278, 39155–39165. (doi:10.1074/jbc.M306409200)
24. Glancy B, Willis WT, Chess DJ, Balaban RS. 2013 Effect of calcium on the oxidative phosphorylation cascade in skeletal muscle mitochondria. Biochemistry 52, 2793–2809. (doi:10.1021/bi3015983)
25. Beard DA. 2005 A biophysical model of the mitochondrial respiratory system and oxidative phosphorylation. PLoS Comput. Biol. 1, e36. (doi:10.1371/journal.pcbi.0010036)
26. Wu F, Yang F, Vinnakota KC, Beard DA. 2007 Computer modeling of mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite transport, and electrophysiology. J. Biol. Chem. 282, 24525–24537. (doi:10.1074/jbc.M701024200)
27. LaNoue KF, Jeffries FM, Radda GK. 1986 Kinetic control of mitochondrial ATP synthesis. Biochemistry 25, 7667–7675. (doi:10.1021/bi00371a058)
28. Wu F, Zhang EY, Zhang J, Bache RJ, Beard DA. 2008 Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts. J. Physiol. 586, 4193–4208. (doi:10.1113/jphysiol.2008.154732)
29. Wu F, Jeneson JA, Beard DA. 2007 Oxidative ATP synthesis in skeletal muscle is controlled by substrate feedback. Am. J. Physiol. Cell Physiol. 292, C115–C124. (doi:10.1152/ajpcell.00237.2006)
30. Wu F, Zhang J, Beard DA. 2009 Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism. Proc. Natl Acad. Sci. USA 106, 7143–7148. (doi:10.1073/pnas.0812768106)
31. Vinnakota KC, Dash RK, Beard DA. 2011 Stimulatory effects of calcium on respiration and NAD(P)H synthesis in intact rat heart mitochondria utilizing physiological substrates cannot explain respiratory control in vivo. J. Biol. Chem. 286, 30816–30822. (doi:10.1074/jbc.M111.242529)
32. Vinnakota KC, Singhal A, Van den Bergh F, Bagher-Oskouei M, Wiseman RW, Beard DA. In press. Openloop stimulation by calcium contributes to control of oxidative phosphorylation in skeletal muscle mitochondria but not in cardiac mitochondria. Biophys. J. (doi:10.1016/j.bpj.2015.12.018)
33. Holmström KM et al. 2015 Assessment of cardiac function in mice lacking the mitochondrial calcium uniporter. J. Mol. Cell. Cardiol. 85, 178–182. (doi:10.1016/j.yjmcc.2015.05.022)
34. Pan X et al. 2013 The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat. Cell Biol. 15, 1464–1472. (doi:10.1038/ncb2868)
35. Kwong JQ et al. 2015 The mitochondrial calcium uniporter selectively matches metabolic output to acute contractile stress in the heart. Cell Rep. 12, 15–22. (doi:10.1016/j.celrep.2015.06.002)
36. Vinnakota KC, Bazil JN, Van den Bergh F, Wiseman RW, Beard DA. In press. Feedback regulation and time hierarchy of oxidative phosphorylation in cardiac mitochondria. Biophys. J.
37. Jeneson JA, Westerhoff HV, Kushmerick MJ. 2000 A metabolic control analysis of kinetic controls in ATP free energy metabolism in contracting skeletal muscle. Am. J. Physiol. Cell Physiol. 279, C813–C832.
38. Rorsman P, Braun M. 2013 Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 75, 155–179. (doi:10.1146/annurevphysiol-030212-183754)
39. Rorsman P, Renstrom E. 2003 Insulin granule dynamics in pancreatic beta cells. Diabetologia 46, 1029–1045. (doi:10.1007/s00125-003-1153-1)
40. Baldwin WMIII, Su CA, Shroka TM, Fairchild RL. 2014 Experimental models of cardiac transplantation: design determines relevance. Curr. Opin. Organ Transplant 19, 525–530. (doi:10.1097/MOT.0000000000000113)
41. Rorsman P, Eliasson L, Kanno T, Zhang Q, Gopel S. 2011 Electrophysiology of pancreatic beta-cells in intact mouse islets of Langerhans. Prog. Biophys. Mol. Biol. 107, 224–235. (doi:10.1016/j.pbiomolbio.2011.06.009)
42. Ashcroft FM, Rorsman P. 2013 K(ATP) channels and islet hormone secretion: new insights and controversies. Nat. Rev. Endocrinol. 9, 660–669. (doi:10.1038/nrendo.2013.166)
43. Frayn KN. 2010 Metabolic regulation: a human perspective, 3rd edn, 384 p. Oxford, UK: Wiley-Blackwell.
44. Ashcroft FM, Rorsman P. 2012 Diabetes mellitus and the beta cell: the last ten years. Cell 148, 1160–1171. (doi:10.1016/j.cell.2012.02.010)
45. Braun M, Ramracheya R, Bengtsson M, Clark A, Walker JN, Johnson PR, Rorsman P. 2010 Gammaaminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 59, 1694–1701. (doi:10.2337/db09-0797)
46. Walker JN, Ramracheya R, Zhang Q, Johnson PR, Braun M, Rorsman P. 2011 Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? Diab. Obes. Metab. 13(Suppl. 1), 95–105. (doi:10.1111/j.1463-1326.2011.01450.x)
47. Rorsman P, Braun M, Zhang Q. 2012 Regulation of calcium in pancreatic alpha-and beta-cells in health and disease. Cell Calcium 51, 300–308. (doi:10.1016/j.ceca.2011.11.006)
48. Braun M, Ramracheya R, Bengtsson M, Zhang Q, Karanauskaite J, Partridge C, Johnson PR, Rorsman P. 2008 Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 57, 1618–1628. (doi:10.2337/db07-0991)
49. Sherman A. 2011 Dynamical systems theory in physiology. J. Gen. Physiol. 138, 13–19. (doi:10.1085/jgp.201110668)
50. Cha CY, Nakamura Y, Himeno Y, Wang J, Fujimoto S, Inagaki N, Earm YE, Noma A. 2011 Ionic mechanisms and Ca2þ dynamics underlying the glucose response of pancreatic beta cells: a simulation study. J. Gen. Physiol. 138, 21–37. (doi:10.1085/jgp.201110611)
51. Gopel SO, Kanno T, Barg S, Eliasson L, Galvanovskis J, Renstrom E, Rorsman P. 1999 Activation of Ca2þdependent Kþ channels contributes to rhythmic firing of action potentials in mouse pancreatic b cells. J. Gen. Physiol. 114, 759–770. (doi:10.1085/jgp.114.6.759)
52. Riz M, Braun M, Pedersen MG. 2014 Mathematical modeling of heterogeneous elctrophysiological responses in human beta cells. PLoS Comput. Biol. 10, e1003389. (doi:10.1371/journal.pcbi.1003389)
53. Zhang M, Houamed K, Kupershmidt S, Roden D, Satin LS. 2005 Pharmacological properties and functional role of Kslow current in mouse pancreatic beta-cells: SK channels contribute to Kslow tail current and modulate insulin secretion. J. Gen. Physiol. 126, 353–363. (doi:10.1085/jgp.200509312)
54. Kanno T, Rorsman P, Göpel SO. 2002 Glucosedependent regulation of rhythmic action potential firing in pancreatic beta-cells by KATP-channel modulation. J. Physiol. 545, 501–507. (doi:10.1113/jphysiol.2002.031344)
55. Rosengren AH et al. 2012 Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 61, 1726–1733. (doi:10.2337/db11-1516)
56. Unoki H et al. 2008 SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40, 1098–1102. (doi:10.1038/ng.208)
57. McCarthy MI. 2008 Casting a wider net for diabetes susceptibility genes. Nat. Genet. 40, 1039–1040. (doi:10.1038/ng0908-1039)
58. Nica AC, Ongen H, Irminger JC, Bosco D, Berney T, Antonarakis SE, Halban PA, Dermitzakis ET. 2013 Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res. 23, 1554–1562. (doi:10.1101/gr.150706.112)
59. Bruin JE et al. 2014 Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells. Stem Cell Res. 12, 194–208. (doi:10.1016/j.scr.2013.10.003)
60. Almaca J, Molina J, Arrojo EDR, Abdulreda MH, Jeon WB, Berggren PO, Caicedo A, Nam HG. 2014 Young capillary vessels rejuvenate aged pancreatic islets. Proc. Natl Acad. Sci. USA 111, 17612–17617. (doi:10.1073/pnas.1414053111)
61. Blandini F, Armentero MT. 2012 Animal models of Parkinson’s disease. FEBS J. 279, 1156–1166. (doi:10.1111/j.1742-4658.2012.08491.x)
62. Langston JW, Ballard P. 1984 Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson’s disease. Can. J. Neurol. Sci. 11(Suppl. 1), 160–165.
63. Hartfield EM, Fernandes HJ, Vowles J, Cowley SA, Wade-Martins R. 2012 Cellular reprogramming: a new approach to modelling Parkinson’s disease. Biochem. Soc. Trans. 40, 1152–1157. (doi:10.1042/BST20120159)
64. Takahashi K, Yamanaka S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676. (doi:10.1016/j.cell.2006.07.024)
65. Hartfield EM, Yamasaki-Mann M, Ribeiro Fernandes HJ, Vowles J, James WS, Cowley SA, Wade-Martins R. 2014 Physiological characterisation of human iPSderived dopaminergic neurons. PLoS ONE 9, e87388. (doi:10.1371/journal.pone.0087388)
66. Camnasio S et al. 2012 The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol. Dis. 46, 41–51. (doi:10.1016/j.nbd.2011.12.042)
67. Israel MA et al. 2012 Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature 482, 216–220. (doi:10.1038/nature10821)
68. Karakikes I et al. 2014 Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy. Nat. Commun. 6, 6955. (doi:10.1038/ncomms7955)
69. Karakikes I, Ameen M, Termglinchan V, Wu JC. 2015 Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ. Res. 117, 80–88. (doi:10.1161/CIRCRESAHA.117.305365)
70. Lee DF et al. 2015 Modeling familial cancer with induced pluripotent stem cells. Cell 161, 240–254. (doi:10.1016/j.cell.2015.02.045)
71. Ranga A, Gjorevski N, Lutolf MP. 2014 Drug discovery through stem cell-based organoid models. Adv. Drug Deliv. Rev. 69–70, 19–28. (doi:10.1016/j.addr.2014.02.006)
72. Chen V, Chen YH, Downing SE. 1987 An improved isolated working rabbit heart preparation using red cell enhanced perfusate. Yale J. Biol. Med. 60, 209–219.
73. Podesser BK, Hallstrom S, Schima H, Huber L, Weisser J, Kroner A, Fürst W, Wolner E. 1999 The erythrocyte-perfused ‘working heart’ model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts. J. Pharmacol. Toxicol. Methods 41, 9–15. (doi:10.1016/S1056-8719(99)00018-0)
74. Schenkman KA, Beard DA, Ciesielski WA, Feigl EO. 2003 Comparison of buffer and red blood cell perfusion of guinea pig heart oxygenation. Am. J. Physiol. Heart Circ. Physiol. 285, H1819–H1825. (doi:10.1152/ajpheart.00383.2003)
75. Duvelleroy MA, Duruble M, Martin JL, Teisseire B, Droulez J, Cain M. 1976 Blood-perfused working isolated rat heart. J. Appl. Physiol. 41, 603–607.
76. Bergmann SR, Clark RE, Sobel BE. 1979 An improved isolated heart preparation for external assessment of myocardial metabolism. Am. J. Physiol. 236, H644–H661.
77. Chemnitius JM, Burger W, Bing RJ. 1985 Crystalloid and perfluorochemical perfusates in an isolated working rabbit heart preparation. Am. J. Physiol. 249, H285–H292.
78. Segel LD, Rendig SV. 1982 Isolated working rat heart perfusion with perfluorochemical emulsion Fluosol-43. Am. J. Physiol. 242, H485–H489.
79. Gillis AM, Kulisz E, Mathison HJ. 1996 Cardiac electrophysiological variables in blood-perfused and buffer-perfused, isolated, working rabbit heart. Am. J. Physiol. 271, H784–H789.
80. MacDonald VW, Winslow RM. 1992 Oxygen delivery and myocardial function in rabbit hearts perfused with cell-free hemoglobin. J. Appl. Physiol. 72, 476–483.
81. Schenkman KA. 2001 Cardiac performance as a function of intracellular oxygen tension in bufferperfused hearts. Am. J. Physiol. Heart Circ. Physiol. 281, H2463–H2472.
82. Wengrowski AM, Kuzmiak-Glancy S, Jaimes III R, Kay MW. 2014 NADH changes during hypoxia, ischemia, and increased work differ between isolated heart preparations. Am. J. Physiol. Heart Circ. Physiol. 306, H529–H537. (doi:10.1152/ajpheart.00696.2013)
83. Tamura M, Oshino N, Chance B, Silver IA. 1978 Optical measurements of intracellular oxygen concentrations of rat heart in vitro. Arch. Biochem. Biophys. 191, 18–22. (doi:10.1016/0003-9861(78)90062-0)
84. Chess DJ, Billings E, Covian R, Glancy B, French S, Taylor J, de Bari H, Murphy E, Balaban RS. 2013 Optical spectroscopy in turbid media using an integrating sphere: mitochondrial chromophore analysis during metabolic transitions. Anal. Biochem. 439, 161–172. (doi:10.1016/j.ab.2013.04.017)
85. Wikstrom M, Morgan JE. 1992 The dioxygen cycle. Spectral, kinetic, and thermodynamic characteristics of ferryl and peroxy intermediates observed by reversal of the cytochrome oxidase reaction. J. Biol. Chem. 267, 10266–10273.
86. Heineman FW, Kupriyanov VV, Marshall R, Fralix TA, Balaban RS. 1992 Myocardial oxygenation in the isolated working rabbit heart as a function of work. Am. J. Physiol. 262, H255–H267.
87. Arai AE, Kasserra CE, Territo PR, Gandjbakhche AH, Balaban RS. 1999 Myocardial oxygenation in vivo: optical spectroscopy of cytoplasmic myoglobin and mitochondrial cytochromes. Am. J. Physiol. 277, H683–H697.
88. Cnota JF, Mays WA, Knecht SK, Kopser S, Michelfelder EC, Knilans TK, Claytor RP, Kimball TR. 2003 Cardiovascular physiology during supine cycle ergometry and dobutamine stress. Med. Sci. Sports Exerc. 35, 1503–1510. (doi:10.1249/01.MSS.0000084436.15808.52)
89. Mehrotra P, Labib SB, Schick EC. 2012 Differential effects of dobutamine versus treadmill exercise on left ventricular volume and wall stress. J. Am. Soc. Echocardiogr. 25, 911–918. (doi:10.1016/j.echo.2012.05.002)
90. La Gerche A et al. 2012 Cardiac magnetic resonance imaging: a new gold standard for ventricular volume quantification during high-intensity exercise. Circ. Cardiovasc. Imaging 6, 329–338. (doi:10.1161/CIRCIMAGING.112.980037)
91. Claessen G et al. In press. Accuracy of echocardiography to evaluate pulmonary vascular and right ventricular function during exercise. JACC Cardiovasc. Imaging. (doi:10.1016/j.jcmg.2015.06.018)
92. Chance B, Connelly CM. 1957 A method for the estimation of the increase in concentration of adenosine diphosphate in muscle sarcosomes following a contraction. Nature 179, 1235–1237. (doi:10.1038/1791235a0)
93. Hochachka PW, McClelland GB. 1997 Cellular metabolic homeostasis during large-scale change in ATP turnover rates in muscles. J. Exp. Biol. 200, 381–386.
94. Burt CT, Glonek T, Barany M. 1977 Analysis of living tissue by phosphorus-31 magnetic resonance. Science 195, 145–149. (doi:10.1126/science.188132)
95. Dawson J, Gadian DG, Wilkie DR. 1976 Proceedings: living muscle studied by 31P nuclear magnetic resonance. J. Physiol. 258, 82P–83P.
96. Ackerman JJ, Grove TH, Wong GG, Gadian DG, Radda GK. 1980 Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature 283, 167–170. (doi:10.1038/283167a0)
97. Chance B, Eleff S, Leigh Jr. JS. 1980 Noninvasive, nondestructive approaches to cell bioenergetics. Proc. Natl Acad. Sci. USA 77, 7430–7434. (doi:10.1073/pnas.77.12.7430)
98. Radda GK. 1986 The use of NMR spectroscopy for the understanding of disease. Science 233, 640–645. (doi:10.1126/science.3726553)
99. Argov Z, Bank WJ, Maris J, Eleff S, Kennaway NG, Olson RE, Chance B. 1986 Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Ann. Neurol. 19, 598–602. (doi:10.1002/ana.410190615)
100. Veech RL, Lawson JW, Cornell NW, Krebs HA. 1979 Cytosolic phosphorylation potential. J. Biol. Chem. 254, 6538–6547.
101. Taylor DJ, Styles P, Matthews PM, Arnold DA, Gadian DG, Bore P, Radda GK. 1986 Energetics of human muscle: exercise-induced ATP depletion. Magn. Reson. Med. 3, 44–54. (doi:10.1002/mrm.1910030107)
102. Sahlin K, Alvestrand A, Brandt R, Hultman E. 1978 Intracellular pH and bicarbonate concentration in human muscle during recovery from exercise. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 45, 474–480.
103. Balaban RS. 1990 Regulation of oxidative phosphorylation in the mammalian cell. Am. J. Physiol. 258, C377–C389.
104. Prompers JJ, Jeneson JA, Drost MR, Oomens CC, Strijkers GJ, Nicolay K. 2006 Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed. 19, 927–953. (doi:10.1002/nbm.1095)
105. Rodenburg JB, de Boer RW, Jeneson JA, van Echteld CJ, Bar PR. 1994 31P-MRS and simultaneous quantification of dynamic human quadriceps exercise in a whole body MR scanner. J. Appl. Physiol. 77, 1021–1029.
106. Richardson RS, Noyszewski EA, Kendrick KF, Leigh JS, Wagner PD. 1995 Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport. J. Clin. Invest. 96, 1916–1926. (doi:10.1172/JCI118237)
107. Jeneson JA, Bruggeman FJ. 2004 Robust homeostatic control of quadriceps pH during natural locomotor activity in man. FASEB J. 18, 1010–1012. (doi:10.1096/fj.03-0762fje)
108. Wasserman K, Whipp BJ, Casaburi R, Golden M, Beaver WL. 1979 Ventilatory control during exercise in man. Bull. Eur. Physiopathol. Respir. 15, 27–51.
109. Koyal SN, Whipp BJ, Huntsman D, Bray GA, Wasserman K. 1976 Ventilatory responses to the metabolic acidosis of treadmill and cycle ergometry. J. Appl. Physiol. 40, 864–867.
110. Jeneson JA, Schmitz JP, Hilbers PA, Nicolay K. 2010 An MR-compatible bicycle ergometer for in-magnet whole-body human exercise testing. Magn. Reson. Med. 63, 257–261.
111. Schmitz JP, van Dijk JP, Hilbers PA, Nicolay K, Jeneson JA, Stegeman DF. 2012 Unchanged muscle fiber conduction velocity relates to mild acidosis during exhaustive bicycling. Eur. J. Appl. Physiol. 112, 1593–1602. (doi:10.1007/s00421-011-2119-5)
112. van Brussel M, van Oorschot JWM, Schmitz JPJ, Nicolay K, Van Royen-Kerkhof A, Takken T, Jeneson JAL. 2015 Muscle metabolic responses during dynamic in-magnet exercise testing: a pilot study in children with an idiopathic inflammatory myopathy. Acad. Radiol. 22, 1443–1448. (doi:10.1016/j.acra.2015.06.013)